β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (574) π οΈ Industry Q&A (121) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ§© Revenue Segmentation by Product
Switch to Location
| Fiscal year | Segment | Value |
|---|---|---|
| 2025 | Biopharma Segment | 61.2B |
| 2024 | Biopharma Segment | 62.4B |
| 2024 | Biopharma Segment | 8.39B |
| 2023 | Business Innovation Segment | 1.31B |
| 2023 | Biopharma Segment | 57.19B |
| 2023 | Biopharma Segment | 7.58B |
| 2022 | Biopharma Segment | 98.99B |
| 2022 | Biopharma Segment | 8.54B |
| 2021 | Biopharma Segment | 79.56B |
π° Explore more revenue segmentation data for Pfizer!
Sign up for free or log inπ Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"